Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial

NCT03066622 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT03066622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial
Lead sponsor
HealthPartners Institute
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2016
Completion date
May 20, 2018
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache